Skip to main content
Log in

Clinical presentation and treatment outcomes of arterial involvement in Behçet’s disease: a single-centre experience

  • Observational Research
  • Published:
Rheumatology International Aims and scope Submit manuscript

Abstract

Arterial involvement, although rare, accounts for significant mortality and morbidity in patients of Behçet’s disease (BD). There is paucity of data on arterial BD. The objective of this 5-year retrospective cohort study was to examine the clinical presentation, pattern of arterial involvement, and treatment outcome in Indian arterial BD patients. Data on demography, clinical presentation, radiology, instituted therapy, vascular interventions and treatment outcomes were recorded and analyzed. Ten (16.9%) out of 59 patients with BD had arterial involvement in 13 vascular territories [mean age 30 (8) years, 9 (90%) males]. Pulmonary artery was most commonly involved (46%), followed by abdominal aorta (15%), femoral artery (15%), descending thoracic aorta (8%), common iliac (8%), and dorsalis pedis artery (8%). Two patients had multi-territory involvement. The median interval between disease onset and development of arterial aneurysms was 3 years (3 months–12 years). Concomitant deep vein thrombosis was seen in 60% cases. Prednisolone and cyclophosphamide were the most common immunosuppressive therapy used; one patient who relapsed on cyclophosphamide responded to infliximab. Five surgical or endovascular interventions were performed. Four patients (40%) died due to aneurysm rupture—all had a delayed diagnosis, and three had pulmonary artery involvement, with death due to massive hemoptysis. Based on the present study, we concluded that arterial involvement in BD is seen predominantly in males and has a high mortality. Early detection and aggressive treatment with immunosuppression and surgical or endovascular interventions are essential for good outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Availability of data and materials

All data generated or analysed during this study are included in this published article.

Code availability

Not applicable.

References

  1. Jennette JC, Falk RJ, Bacon PA, Basu N, Cid MC, Ferrario F et al (2013) 2012 Revised international Chapel Hill consensus conference nomenclature of vasculitides. Arthritis Rheum 65:1–11

    Article  CAS  Google Scholar 

  2. Dilsen N (1996) History and development of Behçet’s disease. Rev Rhum Engl Ed 63:512–519

    CAS  PubMed  Google Scholar 

  3. Zou J, Luo JF, Shen Y, Cai JF, Guan JL (2021) Cluster analysis of phenotypes of patients with Behçet’s syndrome: a large cohort study from a referral center in China. Arthritis Res Ther 23(1):45

    Article  Google Scholar 

  4. Soejima Y, Kirino Y, Takeno M, Kurosawa M, Takeuchi M, Yoshimi R et al (2021) Changes in the proportion of clinical clusters contribute to the phenotypic evolution of Behçet’s disease in Japan. Arthritis Res Ther 23(1):49

    Article  CAS  Google Scholar 

  5. Seyahi E (2019) Phenotypes in Behçet’s syndrome. Intern Emerg Med 14:677

    Article  Google Scholar 

  6. Emmi G, Bettiol A, Silvestri E, Di Scala G, Becatti M, Fiorillo C et al (2019) Vascular Behçet’s syndrome: an update. Intern Emerg Med 14:645–652

    Article  Google Scholar 

  7. Becatti M, Emmi G, Bettiol A, Silvestri E, Di Scala G, Taddei N et al (2019) Behçet’s syndrome as a tool to dissect the mechanisms of thrombo-inflammation: clinical and pathogenetic aspects. Clin Exp Immunol 195:322–333

    Article  CAS  Google Scholar 

  8. Saadoun D, Wechsler B, Desseaux K, Le Thi HD, Amoura Z, Resche-Rigon M et al (2010) Mortality in Behçet’s disease. Arthritis Rheum 62:2806–2812

    Article  CAS  Google Scholar 

  9. Park JH, Han MC, Bettmann MA (1984) Arterial manifestations of Behçet disease. Am J Roentgenol 143(4):821–825

    Article  CAS  Google Scholar 

  10. Tascilar K, Melikoglu M, Ugurlu S, Sut N, Caglar E, Yazici H (2014) Vascular involvement in Behçet’s syndrome: a retrospective analysis of associations and the time course. Rheumatology (Oxford) 53:2018–2022

    Article  CAS  Google Scholar 

  11. Desbois AC, Biard L, Addimanda O, Lambert M, Hachulla E, Launay D et al (2018) Efficacy of anti-TNF alpha in severe and refractory major vessel involvement of Behçet’s disease: a multicenter observational study of 18 patients. Clin Immunol 197:54–59

    Article  CAS  Google Scholar 

  12. Zhang X, Dai H, Ma Z, Yang Y, Liu Y (2015) Pulmonary involvement in patients with Behçet’s disease: report of 15 cases. Clin Respir J 9:414–422

    Article  Google Scholar 

  13. Kalko Y, Basaran M, Aydin U, Kafa U, Basaranoglu G, Yasar T (2005) The surgical treatment of arterial aneurysms in Behçet disease: a report of 16 patients. J Vasc Surg 42:673–677

    Article  Google Scholar 

  14. El-Ghobashy N, El-Garf K, Abdo M (2019) Arterial aneurysms in Behçet’s disease patients: frequency, clinical characteristics and long-term outcome. Egypt Rheumatol 41:309–312

    Article  Google Scholar 

  15. Salimi J, Omrani Z, Cheraghali R (2021) Behçet’s disease and multiple arterial aneurysms: 4 case reports. J Surg Case Rep 27(5):rjab200

    Article  Google Scholar 

  16. International Team for the Revision of the International Criteria for Behçet’s Disease (ITR-ICBD) (2014) The International Criteria for Behçet’s Disease (ICBD): a collaborative study of 27 countries on the sensitivity and specificity of the new criteria. J Eur Acad Dermatol Venereol 28:338–347

    Article  Google Scholar 

  17. Chattopadhyay A, Salvania A, Jain S, Sharma A (2019) A blind man with an acute abdomen. Rheumatology (Oxford) 58:858

    Article  Google Scholar 

  18. Chhabria B, Sharma A, Agarwal R, Muthu V (2019) An unusual cause of massive hemoptysis: the demise of clinical history and a teachable moment from a fatal case. Lung India 36:365–366

    Article  Google Scholar 

  19. Yazici H, Seyahi E, Hatemi G, Yazici Y (2018) Behçet syndrome: a contemporary view. Nat Rev Rheumatol 14:107–119

    Article  CAS  Google Scholar 

  20. Melikoglu M, Kural-Seyahi E, Tascilar K, Yazici H (2008) The unique features of vasculitis in Behçet’s syndrome. Clin Rev Allergy Immunol 35:40–46

    Article  CAS  Google Scholar 

  21. Hatemi G, Christensen R, Bang D, Bodaghi B, Celik AF, Fortune F et al (2018) 2018 update of the EULAR recommendations for the management of Behçet’s syndrome. Ann Rheum Dis 77:808–818

    PubMed  Google Scholar 

  22. Alibaz-Oner F, Direskeneli H (2019) Management of vascular Behçet’s disease. Int J Rheum Dis 22(Suppl 1):105–108

    Article  Google Scholar 

  23. Hamuryudan V, Seyahi E, Ugurlu S, Melikoglu M, Hatemi G, Ozguler Y et al (2015) Pulmonary artery involvement in Behçet’s syndrome: effects of anti-Tnf treatment. Semin Arthritis Rheum 45:369–373

    Article  CAS  Google Scholar 

  24. Rossi GM, Emmi G, Vaglio A (2018) Hemoptysis in Behçet’s syndrome: from bedside to bench? Intern Emerg Med 13:467–469

    Article  Google Scholar 

  25. Voiriot G, Parrot A, Antoine M, Gibelin A, Haddad S, Carette MF et al (2018) Transcatheter embolo-therapy of pulmonary artery aneurysms as emergency treatment of hemoptysis in Behçet patients: experience of a referral center and a review of the literature. Intern Emerg Med 13:491–500

    Article  Google Scholar 

Download references

Funding

No specific funding was received from any bodies in the public, commercial or not-for-profit sectors to carry out the work described in this article.

Author information

Authors and Affiliations

Authors

Contributions

AC and AmS conceptualized the study. AC, SiJ, BC and NA collected, analysed and interpreted the data. AC, SiJ and AmS drafted the manuscript. GN, VD, VM, AjS, RV and SaJ provided critical, intellectual inputs on the same. MS interpreted and analysed the radiological data. AjS was involved in surgical management, while RV performed percutaneous interventions. All co-authors approved the final submitted version of the manuscript. All co-authors take full responsibility for all aspects of the work and meet all four criteria for authorship recommended by the ICMJE.

Corresponding author

Correspondence to Aman Sharma.

Ethics declarations

Conflict of interest

The authors declare no conflicts of interest.

Ethics approval

This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Institutional Ethics Committee of Postgraduate Institute of Medical Education and Research, Chandigarh, India (INT/IEC/2021/SPL-126, dated 22.01.2021).

Consent to participate

Informed consent was obtained from all individual participants included in the study.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Chattopadhyay, A., Jain, S., Naidu, G.S.R.S.N.K. et al. Clinical presentation and treatment outcomes of arterial involvement in Behçet’s disease: a single-centre experience. Rheumatol Int 42, 115–120 (2022). https://doi.org/10.1007/s00296-021-05022-y

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00296-021-05022-y

Keywords

Navigation